CCAP Stock: Analyst Targets Suggest +24% Upside for Crescent Capital BDC

Key Takeaways

• The central target of $11.50 is the arithmetic mean of seven current analyst price targets reviewed for this article, rounded from a calculated average of roughly $11.54.
• The individual targets range from a low of $10.00 to a high of $14.00, reflecting a wide split between cautious and more constructive analysts.
• With the stock trading near $9.30, reaching $11.50 would require a rise of roughly 24% — a large move for a dividend-paying BDC.
• The strongest supporting factors are a deep discount to net asset value (NAV), a high dividend yield, and a recent earnings beat; the biggest risk is credit deterioration in the loan portfolio.
• Sentiment has cooled through 2026, with multiple firms cutting targets and at least two downgrades in recent months.
• For more detail on CCAP's Major News, Today's Price Move, Forecast, and Earnings, explore the additional pages.
• Readers looking for systematic trade ideas can explore Trending AI Robots.

Breaking Down the Analyst Targets

Seven analyst price targets were reviewed for this analysis: Raymond James at $10 (Outperform, October 22, 2026), Clear Street at $11 (Buy, October 21, 2026), Bank of America Securities at $10.25 (Neutral, September 10, 2026), Keefe, Bruyette & Woods at $12 (Market Perform, August 17, 2026), Wells Fargo at $11 (Equal Weight, August 12, 2026), Ladenburg Thalmann at $14 (Buy, August 12, 2026), and B. Riley at $12.50 (Neutral, August 12, 2026). The average is about $11.54, which rounds to the $11.50 central target used throughout. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how recent patterns align with these views.

The range — $10.00 to $14.00 — is unusually wide for a single BDC, signaling genuine disagreement. The mix is three Buy ratings and four Hold/Neutral ratings, with no Sells. Notably, firms have been trimming expectations: Raymond James lowered its target from $12 to $10, Clear Street from $15.50 to $11, and Bank of America from $13 to $10.25 while downgrading the stock to Neutral. The cautious view centers on portfolio credit risk; the more constructive view emphasizes the stock's deep discount to its underlying value.

Where CCAP Stands Today

As of early November 2026, CCAP trades near $9.30, well below its 52-week high of $15.18 and not far above its 52-week low of $8.40. Reaching $11.50 implies an upside of about 24%, a large required move for an income-oriented name. The stock's price-to-book ratio sits near 0.5x, meaning shares change hands at a substantial discount to NAV of roughly $17 per share — a valuation that leaves room for recovery if credit metrics stabilize, but one that also reflects investor skepticism about the portfolio.

Fundamentally, the company's most recent quarterly report showed adjusted earnings per share of $0.37, modestly above consensus of $0.35, with revenue slightly ahead of estimates. A dividend yield in the mid-teens is central to the bull case, though a payout is only as durable as the underlying loan portfolio's performance.

Factors That Could Drive CCAP Higher

Several factors could help CCAP close the gap toward $11.50. The valuation discount to NAV is arguably the strongest anchor: if credit quality holds and non-accruals remain contained, the shares could re-rate higher. Persistently elevated interest rates support floating-rate loan income, a direct driver of NII for middle-market lenders. The recent earnings beat, a double-digit dividend yield, and the fact that no analyst carries a Sell rating all suggest the market may be pricing in a worst-case scenario that has not yet materialized. A sustained recovery in the broader credit cycle would be the clearest catalyst.

Risks on the Horizon

The principal obstacle is credit risk. As a lender to middle-market companies, CCAP is exposed to borrower defaults and markdowns on its investments, which directly pressure NAV and can force a dividend reduction. The steady stream of analyst target cuts and downgrades through 2026 — including Bank of America and Keefe Bruyette moving to neutral stances — indicates that several research desks see elevated risk in the portfolio. A lower-rate environment, while easing borrower stress, could also reduce floating-rate income. Finally, trading well below NAV can persist for extended periods, meaning a cheap valuation is not, by itself, a catalyst.

Key Technical Levels to Watch

The $10.00 level is significant: it is both a psychological round number and a cluster of analyst targets, and it sits just above the current price. Below that, the 52-week low near $8.40 represents key support. On the upside, the stock would need to reclaim the $11–$12 zone — where several targets cluster and where shares traded through much of the summer — before the $12.50–$14.00 range, the upper band of analyst expectations, comes into view. The broader structure remains one of a stock that rallied sharply in 2026 before giving back a large portion of those gains.

What to Keep an Eye On

Analyst price targets for BDCs generally reflect a research horizon of about 12 months, though individual firms vary. Investors should watch quarterly NII and the trend in non-accrual loans, changes to the regular or supplemental dividend, and any revisions to NAV per share. Further analyst rating or target changes will matter, as will the Federal Open Market Committee (FOMC) interest-rate path, given its impact on both loan yields and borrower default risk. The next earnings report and accompanying commentary on portfolio credit quality are the most immediate signposts.

Final Assessment

The $11.50 central target is a calculated average of seven current analyst price targets, not a published consensus, and it sits roughly 24% above the recent price of about $9.30. The bull case rests on a deep discount to NAV, a high yield, and a recent earnings beat; the bear case rests on credit deterioration, dividend sustainability, and a year of downward target revisions. With targets spanning $10 to $14 and a split between Buy and Hold ratings, the outcome will hinge on whether the loan portfolio's credit quality stabilizes. Investors should monitor NII, non-accruals, the dividend, and FOMC policy rather than treat any single price target as a forecast.

My Experience with Tickeron AI Tools

In my own work, I often turn to Tickeron’s AI Daily Buy/Sell Signals to monitor names like CCAP where sentiment can shift quickly. The platform uses artificial intelligence to scan thousands of stocks and ETFs, delivering Buy, Sell, or Hold signals based on technical behavior and market conditions. It has helped me spot trend changes and complement fundamental research without replacing it.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Notable companies

Industry description

Market Cap

High and low price notable news

Volume